ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Nascent Biotech Inc (CE)

Nascent Biotech Inc (CE) (NBIO)

0,0075
-0,0015
( -16,67% )
Aktualisiert: 16:40:33

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,0075
Gebot
0,00
Fragen
0,00
Volumen
24.200
0,0075 Tagesbereich 0,009
0,0002 52-Wochen-Bereich 0,19
Marktkapitalisierung
Handelsende
0,009
Handelsbeginn
0,009
Letzte Trade
8200
@
0.0075
Letzter Handelszeitpunkt
16:40:33
Finanzvolumen
US$ 218
VWAP
0,009
Durchschnittliches Volumen (3 Mio.)
74.899
Ausgegebene Aktien
172.202.165
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,83
Gewinn pro Aktie (EPS)
-0,01
Erlöse
-
Nettogewinn
-2,09M

Über Nascent Biotech Inc (CE)

Nascent Biotech is a clinical stage bio-pharmaceutical company whose Investigational New Drug (IND) application was cleared in December 2018, by the US Food and Drug Administration (FDA),and has completed Phase I human trials on brain cancer patients with its monoclonal antibody product Pritumumab. ... Nascent Biotech is a clinical stage bio-pharmaceutical company whose Investigational New Drug (IND) application was cleared in December 2018, by the US Food and Drug Administration (FDA),and has completed Phase I human trials on brain cancer patients with its monoclonal antibody product Pritumumab. The Company has submitted to the FDA for clearance to begin phase 2 clinical trials. . The objective of the Phase 2 human clinical trial is to assess potential efficacy in reducing the size or eliminating brain tumors, both primary and metastatic. Nascent is focused on developing Pritumumab for the treatment of patients with brain cancer malignancies such as Gliomas and Astrocytoma's. Current therapeutic strategies include chemotherapy, radiation and/or surgery. There exists a need to develop safer more effective drugs and treatment options for this deadly cancer. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Vero Beach, Florida, USA
Gegründet
-
Nascent Biotech Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NBIO. The last closing price for Nascent Biotech (CE) was US$0,01. Over the last year, Nascent Biotech (CE) shares have traded in a share price range of US$ 0,0002 to US$ 0,19.

Nascent Biotech (CE) currently has 172.202.165 shares in issue. The market capitalisation of Nascent Biotech (CE) is US$1,55 million. Nascent Biotech (CE) has a price to earnings ratio (PE ratio) of -0.83.

NBIO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0015-16.66666666670.0090.0090.007530000.009CS
40.0064000.00150.0090.0015354640.00454078CS
12-0.0545-87.90322580650.0620.069480.0002748990.04634522CS
26-0.03225-81.13207547170.039750.095150.00021010690.05173686CS
52-0.0826-91.67591564930.09010.190.0002978070.06291279CS
156-0.0445-85.57692307690.0520.480.00021928310.13680908CS
260-0.1175-940.1250.480.00021924810.11480488CS

NBIO - Frequently Asked Questions (FAQ)

What is the current Nascent Biotech (CE) share price?
The current share price of Nascent Biotech (CE) is US$ 0,0075
How many Nascent Biotech (CE) shares are in issue?
Nascent Biotech (CE) has 172.202.165 shares in issue
What is the market cap of Nascent Biotech (CE)?
The market capitalisation of Nascent Biotech (CE) is USD 1,55M
What is the 1 year trading range for Nascent Biotech (CE) share price?
Nascent Biotech (CE) has traded in the range of US$ 0,0002 to US$ 0,19 during the past year
What is the PE ratio of Nascent Biotech (CE)?
The price to earnings ratio of Nascent Biotech (CE) is -0,83
What is the reporting currency for Nascent Biotech (CE)?
Nascent Biotech (CE) reports financial results in USD
What is the latest annual profit for Nascent Biotech (CE)?
The latest annual profit of Nascent Biotech (CE) is USD -2,09M
What is the registered address of Nascent Biotech (CE)?
The registered address for Nascent Biotech (CE) is 623 17TH STREET, SUITE 4, VERO BEACH, FLORIDA, 32960
What is the Nascent Biotech (CE) website address?
The website address for Nascent Biotech (CE) is www.nascentbiotech.com
Which industry sector does Nascent Biotech (CE) operate in?
Nascent Biotech (CE) operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ELYSElys BMG Group Inc (CE)
US$ 0,0004
(39.900,00%)
5k
WEJOFWejo Group Ltd (CE)
US$ 0,0001
(9.900,00%)
111
SIRCSolar Integrated Roofing Corporation (PK)
US$ 0,0001
(9.900,00%)
10,71M
NXTPNextPlay Technologies Inc (CE)
US$ 0,0001
(9.900,00%)
2,15k
MFLTYMissfresh Ltd (CE)
US$ 0,0001
(9.900,00%)
103
FVTIFortune Valley Treasures Inc (CE)
US$ 0,0011
(-99,56%)
200
IMTLImage Protect Inc (PK)
US$ 0,000001
(-99,50%)
571,68k
BQSTBioQuest Corporation (PK)
US$ 0,0102
(-99,03%)
1.000
BRAVBravada International Limited (CE)
US$ 0,000001
(-99,00%)
188,96k
AHFDActive Health Foods Inc (CE)
US$ 0,000001
(-99,00%)
500k
BYOCBeyond Commerce Inc (PK)
US$ 0,0001
(-50,00%)
76,28M
HMBLHUMBL Inc (PK)
US$ 0,0004
(-20,00%)
57,41M
HCMCHealthier Choices Management Corporation (PK)
US$ 0,000001
(0,00%)
56,25M
IGEXIndo Global Exchanges Pte Ltd (PK)
US$ 0,001
(11,11%)
55,2M
NSAVNet Savings Link Inc (PK)
US$ 0,00045
(12,50%)
37,9M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock